Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy (NCT05049746)

🧪 Interventions in This Study

• Discussion (OTHER)
• Interview (OTHER)
• Questionnaire Administration (OTHER)

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

1. Patient Inclusion Criteria
2. Women aged 65 years or older
3. Must write and speak English
4. Must have been diagnosed with Stage I-III breast cancer
5. Must have made decision to either receive or not receive neoadjuvant or adjuvant chemotherapy
6. Must be within 3 months of breast cancer neoadjuvant or adjuvant chemotherapy treatment decision
7. Self-reported no visual or auditory deficits
8. SUBAIM 2b: Women aged 65 years or older
9. SUBAIM 2b: Must write and speak English
10. SUBAIM 2b: Must have been diagnosed with stage I-III breast cancer
11. SUBAIM 2b: Must be a candidate for chemotherapy or targeted therapy (in the setting of HER2+ breast cancer)
12. SUBAIM 2b: Must be making a decision regarding chemotherapy

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

• M D Anderson Cancer Center — Houston, Texas

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Anatomic Stage I Breast Cancer AJCC v8

• Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study — Kingman, Arizona
• Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial — Seattle, Washington
• Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients — Rochester, Minnesota
• A Physical Activity Program Compared to Health Education for Improving Memory and Attention in Hispanic Women With Newly-Diagnosed Stage I-IIIa Breast Cancer, MAMA Trial — Scottsdale, Arizona
• Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer — Houston, Texas

Explore by condition: All Anatomic Stage I Breast Cancer AJCC v8 clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.